Copyright Reports & Markets. All rights reserved.

Global Insomnia Medication Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Global Insomnia Medication Market Research Report 2018

      1 Insomnia Medication Market Overview

      • 1.1 Product Overview and Scope of Insomnia Medication
      • 1.2 Insomnia Medication Segment by Type (Product Category)
        • 1.2.1 Global Insomnia Medication Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
        • 1.2.2 Global Insomnia Medication Production Market Share by Type (Product Category) in 2017
        • 1.2.3 Nonbenzodiazepine Receptor Agonists
        • 1.2.3 Benzodiazepine Receptor Agonists
        • 1.2.5 The Selective Melatonin Receptor Agonist Ramelteon

      Sedating Antidepressants

      • 1.3 Global Insomnia Medication Segment by Application
        • 1.3.1 Insomnia Medication Consumption (Sales) Comparison by Application (2013-2025)
        • 1.3.2 Adults
        • 1.3.3 Kids
      • 1.4 Global Insomnia Medication Market by Region (2013-2025)
        • 1.4.1 Global Insomnia Medication Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
        • 1.4.2 North America Status and Prospect (2013-2025)
        • 1.4.3 Europe Status and Prospect (2013-2025)
        • 1.4.4 China Status and Prospect (2013-2025)
        • 1.4.5 Japan Status and Prospect (2013-2025)
        • 1.4.6 Southeast Asia Status and Prospect (2013-2025)
        • 1.4.7 India Status and Prospect (2013-2025)
      • 1.5 Global Market Size (Value) of Insomnia Medication (2013-2025)
        • 1.5.1 Global Insomnia Medication Revenue Status and Outlook (2013-2025)
        • 1.5.2 Global Insomnia Medication Capacity, Production Status and Outlook (2013-2025)

      2 Global Insomnia Medication Market Competition by Manufacturers

      • 2.1 Global Insomnia Medication Capacity, Production and Share by Manufacturers (2013-2018)
        • 2.1.1 Global Insomnia Medication Capacity and Share by Manufacturers (2013-2018)
        • 2.1.2 Global Insomnia Medication Production and Share by Manufacturers (2013-2018)
      • 2.2 Global Insomnia Medication Revenue and Share by Manufacturers (2013-2018)
      • 2.3 Global Insomnia Medication Average Price by Manufacturers (2013-2018)
      • 2.4 Manufacturers Insomnia Medication Manufacturing Base Distribution, Sales Area and Product Type
      • 2.5 Insomnia Medication Market Competitive Situation and Trends
        • 2.5.1 Insomnia Medication Market Concentration Rate
        • 2.5.2 Insomnia Medication Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Insomnia Medication Capacity, Production, Revenue (Value) by Region (2013-2018)

      • 3.1 Global Insomnia Medication Capacity and Market Share by Region (2013-2018)
      • 3.2 Global Insomnia Medication Production and Market Share by Region (2013-2018)
      • 3.3 Global Insomnia Medication Revenue (Value) and Market Share by Region (2013-2018)
      • 3.4 Global Insomnia Medication Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.5 North America Insomnia Medication Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.6 Europe Insomnia Medication Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.7 China Insomnia Medication Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.8 Japan Insomnia Medication Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.9 Southeast Asia Insomnia Medication Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.10 India Insomnia Medication Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

      4 Global Insomnia Medication Supply (Production), Consumption, Export, Import by Region (2013-2018)

      • 4.1 Global Insomnia Medication Consumption by Region (2013-2018)
      • 4.2 North America Insomnia Medication Production, Consumption, Export, Import (2013-2018)
      • 4.3 Europe Insomnia Medication Production, Consumption, Export, Import (2013-2018)
      • 4.4 China Insomnia Medication Production, Consumption, Export, Import (2013-2018)
      • 4.5 Japan Insomnia Medication Production, Consumption, Export, Import (2013-2018)
      • 4.6 Southeast Asia Insomnia Medication Production, Consumption, Export, Import (2013-2018)
      • 4.7 India Insomnia Medication Production, Consumption, Export, Import (2013-2018)

      5 Global Insomnia Medication Production, Revenue (Value), Price Trend by Type

      • 5.1 Global Insomnia Medication Production and Market Share by Type (2013-2018)
      • 5.2 Global Insomnia Medication Revenue and Market Share by Type (2013-2018)
      • 5.3 Global Insomnia Medication Price by Type (2013-2018)
      • 5.4 Global Insomnia Medication Production Growth by Type (2013-2018)

      6 Global Insomnia Medication Market Analysis by Application

      • 6.1 Global Insomnia Medication Consumption and Market Share by Application (2013-2018)
      • 6.2 Global Insomnia Medication Consumption Growth Rate by Application (2013-2018)
      • 6.3 Market Drivers and Opportunities
        • 6.3.1 Potential Applications
        • 6.3.2 Emerging Markets/Countries

      7 Global Insomnia Medication Manufacturers Profiles/Analysis

      • 7.1 Eisai
        • 7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.1.2 Insomnia Medication Product Category, Application and Specification
          • 7.1.2.1 Product A
          • 7.1.2.2 Product B
        • 7.1.3 Eisai Insomnia Medication Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.1.4 Main Business/Business Overview
      • 7.2 Merck
        • 7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.2.2 Insomnia Medication Product Category, Application and Specification
          • 7.2.2.1 Product A
          • 7.2.2.2 Product B
        • 7.2.3 Merck Insomnia Medication Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.2.4 Main Business/Business Overview
      • 7.3 Pfizer
        • 7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.3.2 Insomnia Medication Product Category, Application and Specification
          • 7.3.2.1 Product A
          • 7.3.2.2 Product B
        • 7.3.3 Pfizer Insomnia Medication Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.3.4 Main Business/Business Overview
      • 7.4 Sanofi
        • 7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.4.2 Insomnia Medication Product Category, Application and Specification
          • 7.4.2.1 Product A
          • 7.4.2.2 Product B
        • 7.4.3 Sanofi Insomnia Medication Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.4.4 Main Business/Business Overview
      • 7.5 Takeda
        • 7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.5.2 Insomnia Medication Product Category, Application and Specification
          • 7.5.2.1 Product A
          • 7.5.2.2 Product B
        • 7.5.3 Takeda Insomnia Medication Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
        • 7.5.4 Main Business/Business Overview
      • 7.6 Vanda Pharmaceuticals
        • 7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.6.2 Insomnia Medication Product Category, Application and Specification
          • 7.6.2.1 Product A
          • 7.6.2.2 Product B
        • 7.6.3 Vanda Pharmaceuticals Insomnia Medication Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.6.4 Main Business/Business Overview
      • 7.7 Astellas
        • 7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.7.2 Insomnia Medication Product Category, Application and Specification
          • 7.7.2.1 Product A
          • 7.7.2.2 Product B
        • 7.7.3 Astellas Insomnia Medication Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.7.4 Main Business/Business Overview
      • 7.8 Dainippon Sumitomo
        • 7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.8.2 Insomnia Medication Product Category, Application and Specification
          • 7.8.2.1 Product A
          • 7.8.2.2 Product B
        • 7.8.3 Dainippon Sumitomo Insomnia Medication Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.8.4 Main Business/Business Overview
      • 7.9 ECR Pharmaceuticals (Valeant)
        • 7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.9.2 Insomnia Medication Product Category, Application and Specification
          • 7.9.2.1 Product A
          • 7.9.2.2 Product B
        • 7.9.3 ECR Pharmaceuticals (Valeant) Insomnia Medication Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.9.4 Main Business/Business Overview
      • 7.8 Flynn Pharma
        • 7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.10.2 Insomnia Medication Product Category, Application and Specification
          • 7.10.2.1 Product A
          • 7.10.2.2 Product B
        • 7.10.3 Flynn Pharma Insomnia Medication Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.10.4 Main Business/Business Overview
      • 7.11 Johnson & Johnson
      • 7.12 Meda
      • 7.13 Somnus Therapeutics
      • 7.14 Purdue Pharma
      • 7.15 Neurim
      • 7.16 Minerva Neurosciences
      • 7.17 Pernix Therapeutics
      • 7.18 SkyePharma
      • 7.19 Paratek Pharmaceuticals

      8 Insomnia Medication Manufacturing Cost Analysis

      • 8.1 Insomnia Medication Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
        • 8.1.4 Market Concentration Rate of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
        • 8.2.1 Raw Materials
        • 8.2.2 Labor Cost
        • 8.2.3 Manufacturing Expenses
      • 8.3 Manufacturing Process Analysis of Insomnia Medication

      9 Industrial Chain, Sourcing Strategy and Downstream Buyers

      • 9.1 Insomnia Medication Industrial Chain Analysis
      • 9.2 Upstream Raw Materials Sourcing
      • 9.3 Raw Materials Sources of Insomnia Medication Major Manufacturers in 2017
      • 9.4 Downstream Buyers

      10 Marketing Strategy Analysis, Distributors/Traders

      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
        • 10.1.3 Marketing Channel Development Trend
      • 10.2 Market Positioning
        • 10.2.1 Pricing Strategy
        • 10.2.2 Brand Strategy
        • 10.2.3 Target Client
      • 10.3 Distributors/Traders List

      11 Market Effect Factors Analysis

      • 11.1 Technology Progress/Risk
        • 11.1.1 Substitutes Threat
        • 11.1.2 Technology Progress in Related Industry
      • 11.2 Consumer Needs/Customer Preference Change
      • 11.3 Economic/Political Environmental Change

      12 Global Insomnia Medication Market Forecast (2018-2025)

      • 12.1 Global Insomnia Medication Capacity, Production, Revenue Forecast (2018-2025)
        • 12.1.1 Global Insomnia Medication Capacity, Production and Growth Rate Forecast (2018-2025)
        • 12.1.2 Global Insomnia Medication Revenue and Growth Rate Forecast (2018-2025)
        • 12.1.3 Global Insomnia Medication Price and Trend Forecast (2018-2025)
      • 12.2 Global Insomnia Medication Production, Consumption , Import and Export Forecast by Region (2018-2025)
        • 12.2.1 North America Insomnia Medication Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.2 Europe Insomnia Medication Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.3 China Insomnia Medication Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.4 Japan Insomnia Medication Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.5 Southeast Asia Insomnia Medication Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.6 India Insomnia Medication Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
      • 12.3 Global Insomnia Medication Production, Revenue and Price Forecast by Type (2018-2025)
      • 12.4 Global Insomnia Medication Consumption Forecast by Application (2018-2025)

      13 Research Findings and Conclusion

        14 Appendix

        • 14.1 Methodology/Research Approach
          • 14.1.1 Research Programs/Design
          • 14.1.2 Market Size Estimation
          • 14.1.3 Market Breakdown and Data Triangulation
        • 14.2 Data Source
          • 14.2.1 Secondary Sources
          • 14.2.2 Primary Sources

        This report studies the global Insomnia Medication market status and forecast, categorizes the global Insomnia Medication market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).

        The major manufacturers covered in this report
        Eisai
        Merck
        Pfizer
        Sanofi
        Takeda
        Vanda Pharmaceuticals
        Astellas
        Dainippon Sumitomo
        ECR Pharmaceuticals (Valeant)
        Flynn Pharma
        Johnson & Johnson
        Meda
        Somnus Therapeutics
        Purdue Pharma
        Neurim
        Minerva Neurosciences
        Pernix Therapeutics
        SkyePharma
        Paratek Pharmaceuticals

        Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        We can also provide the customized separate regional or country-level reports, for the following regions:
        North America
        United States
        Canada
        Mexico
        Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Rest of Asia-Pacific
        Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
        Rest of Europe
        Central & South America
        Brazil
        Argentina
        Rest of South America
        Middle East & Africa
        Saudi Arabia
        Turkey
        Rest of Middle East & Africa

        On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
        Nonbenzodiazepine Receptor Agonists
        Benzodiazepine Receptor Agonists
        The Selective Melatonin Receptor Agonist Ramelteon
        Sedating Antidepressants
        On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
        Adults
        Kids

        The study objectives of this report are:
        To analyze and study the global Insomnia Medication capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
        Focuses on the key Insomnia Medication manufacturers, to study the capacity, production, value, market share and development plans in future.
        Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
        To define, describe and forecast the market by type, application and region.
        To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
        To identify significant trends and factors driving or inhibiting the market growth.
        To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
        To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
        To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
        To strategically profile the key players and comprehensively analyze their growth strategies.

        In this study, the years considered to estimate the market size of Insomnia Medication are as follows:
        History Year: 2013-2017
        Base Year: 2017
        Estimated Year: 2018
        Forecast Year 2018 to 2025

        For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

        Key Stakeholders
        Insomnia Medication Manufacturers
        Insomnia Medication Distributors/Traders/Wholesalers
        Insomnia Medication Subcomponent Manufacturers
        Industry Association
        Downstream Vendors

        Available Customizations
        With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
        Regional and country-level analysis of the Insomnia Medication market, by end-use.
        Detailed analysis and profiles of additional market players.

        Buy now